Insider · CIK 0001502700
Michael F Marino III
officer
Files at OPTN (OptiNose, Inc.), NAMS (NewAmsterdam Pharma Co N.V.). First filing Dec 18, 2024, latest Dec 18, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1,342 sold
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2025 | NAMS NewAmsterdam Pharma Co N.V. | AGrant or award Ordinary Shares | +55,000 | - | - | 55,000 | Jun 3, 2025 |
| Jun 1, 2025 | NAMS NewAmsterdam Pharma Co N.V. | AGrant or award Option (right to buy)derivative | +315,000 | $0.00 | $0 | 315,000 | Jun 3, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Common Stock | -125,204 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,575 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -9,333 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,752 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,350 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,333 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,056 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,500 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,775 | - | - | 0 | May 21, 2025 |
| May 21, 2025 | OPTN OptiNose, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -9,626 | - | - | 0 | May 21, 2025 |
| Dec 17, 2024 | OPTN OptiNose, Inc. | SOpen-market sale Common Stock | -3,050 | $0.44 | $1,342 | 544,188 | Dec 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.